People In The News | GenomeWeb

People In The News

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Rosetta Genomics said this week that Brian Markison has become an observer to the company's board of directors and that he will become a director at the firm upon approval. Markison currently is chairman and CEO of King Pharmaceuticals, where he led the company through to its recently announced acquisition by Pfizer, and before that he was at Bristol-Myers Squibb, where he served as president of BMS Oncology/Virology and Oncology Therapeutics Network.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.